Machine learning prioritizes a protective Arabidopsis leaf fungus that suppresses oomycete infection
Four classifiers (random forest, support-vector machine, logistic regression and multilayer perceptron) used six years of natural Arabidopsis leaf-microbiome data to prioritize taxa associated with Albugo infection status. Follow-up plant assays found that selected health-associated microbes reduced infection; Cystofilobasidium macerans OTU126 gave the strongest individual protection, reducing Albugo infection by an average of 73%. In a 15-member synthetic leaf community, adding this fungus increased the reported infection reduction to 40.25%, compared with 19.36% for the community alone.
Technology: Random forest, support-vector machine, logistic regression and multilayer perceptron classifiers with cross-validated feature selection
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Follow-up plant assays found that selected health-associated microbes reduced infection; Cystofilobasidium macerans OTU126 gave the strongest individual protection, reducing Albugo infection by an average of 73%.
- Still unknown: This is a controlled Arabidopsis–Albugo plant-pathogen model, not a field crop efficacy trial. ML features are associations with infection status; they do not establish the microbes caused naturally observed health status. Isolates were matched to predicted OTUs using marker sequences, which the authors note do not fully establish strain-level functional identity. Genomic terpene-cluster hypotheses were not directly tested. No commercial or field-ready biocontrol performance is established.
- AI role: Models classified infected versus uninfected plants from microbial community profiles and prioritized disease-associated and health-associated taxa for follow-up. Researchers then tested selected cultured isolates in planta and tested Cystofilobasidium in a synthetic community.
Evidence sources: https://pubmed.ncbi.nlm.nih.gov/42521687/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.